Prognosis and Side Effects of Inhaled Nitric Oxide Treatment in Persistent Pulmonary Hypertension of the Newborn
Neonatal Medicine
;
: 71-77, 2015.
Article
Dans Coréen
| WPRIM
| ID: wpr-125638
ABSTRACT
Inhaled nitric oxide (iNO) is a potent and selective pulmonary vasodilator agent that improves arterial oxygenation and subsequent clinical outcomes for newborn infants with persistent pulmonary hypertension of the newborn (PPHN). Along with beneficial pharmacological properties, iNO also shows toxicological effects. Although the side effects of iNO have not been fully understood, these need to be thoroughly considered and monitored for the safe and effective clinical use of iNO. This article presents a review of the side effects of iNO and short-term and long-term clinical prognosis in newborn infants > or =34 weeks' gestation with PPHN.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Oxygène
/
Persistance de la circulation foetale
/
Pronostic
/
Hypertension pulmonaire
/
Monoxyde d'azote
Type d'étude:
Étude pronostique
Limites du sujet:
Femelle
/
Humains
/
Nouveau-né
/
Grossesse
langue:
Coréen
Texte intégral:
Neonatal Medicine
Année:
2015
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS